Prenetics Global LtdNASDAQ:PRE
- LAST PRICE4.4200
- TODAY'S CHANGE (%)-0.3000 (-6.3559%)
- Bid / Lots3.7100/ 4
- Ask / Lots4.6300/ 9
- Open / Previous Close4.5200 / 4.7200
- Day Range
- 52 Week Range
- Volume14,742
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRE |
|---|---|---|
| 09:37 ET | 2397 | 4.67 |
| 09:39 ET | 548 | 4.477 |
| 09:42 ET | 1479 | 4.5062 |
| 09:44 ET | 100 | 4.58 |
| 10:11 ET | 100 | 4.59 |
| 10:51 ET | 875 | 4.59 |
| 10:54 ET | 5305 | 4.5 |
| 01:49 ET | 525 | 4.5 |
| 01:56 ET | 1865 | 4.42 |
Nov 18, 2024
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health, from 6:57AM ET on Monday Nov 18, 2024 by Dow Jones
6:57AM ET on Monday Nov 18, 2024 by Dow JonesNasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health, from 6:00AM ET on Monday Nov 18, 2024 by Dow Jones
6:00AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 12, 2024
Sidoti Events, LLC's Virtual November Micro-Cap Conference, from 8:31AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:31AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prenetics Global Ltd | 57.7M | -1.2x | --- |
Celularity Inc | 64.6M | -0.5x | --- |
Aadi Bioscience Inc | 54.7M | -1.0x | --- |
Werewolf Therapeutics Inc | 73.1M | -1.2x | --- |
HOOKIPA Pharma Inc | 32.8M | -0.6x | --- |
Aligos Therapeutics Inc | 65.3M | -1.1x | --- |
Company Information
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.
Contact Information
- Headquarters
- Unit 701-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay, Hong Kong
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Sheng Wu Yeung
- Co-Founder, Chief Scientific Officer
- Chi Hung Tzang
- Chief Financial Officer
- Hoi Chun Lo
- Chief Technology Officer
- Yung Ho Wong
- Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations
- Samantha Kwok
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $57.7M |
|---|---|
Revenue (TTM) | $22.5M |
Shares Outstanding | 12.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.18 |
EPS | $-3.79 |
Book Value | $16.91 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -199.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
